GlassScriptPhysician profile
Curtis Clark
NPI 1962806786
$839.80
in general payments reported to CMS, 2019-2025
14 companies · $371 in 2025
The $371 reported for 2025 was more than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $469 · 2025: $371.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $750 · Education: $89.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $749.81 |
| Education | $89.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harmony Biosciences LLC | $188.84 | 2024-2025 | |
| Avadel Cns Pharmaceuticals, LLC | $133.28 | 2024-2025 | Lumryz |
| Axsome Therapeutics, INC. | $74.48 | 2024-2025 | Sunosi |
| Inspire Medical Systems, INC. | $70.40 | 2024-2025 | Inspire |
| Melinta Therapeutics, LLC | $52.37 | 2024 | Rezzayo, Kimyrsa |
| Abbvie INC. | $51.01 | 2024 | |
| Integra Lifesciences Corporation | $50.58 | 2024-2025 | Cusa Clarity, Codman Hakim, Codman Certas |
| Viatris Specialty LLC | $49.65 | 2025 | Yupelri |
| Amgen INC. | $37.59 | 2025 | Evenity |
| Philips North America LLC | $30.50 | 2025 | Patient Interface Software |
| Exeltis, USA INC. | $29.41 | 2024 | Slynd |
| Lilly USA, LLC | $28.88 | 2025 | Zepbound, Mounjaro |
| Mylan Specialty L.P. | $28.38 | 2024 | Yupelri |
| Fisher & Paykel Healthcare INC | $14.43 | 2024 | Fisher & Paykel Healthcare |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Curtis Clark listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.